Andrew H. Lane - Nov 15, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role: EXECUTIVE VICE PRESIDENT
Signature: /s/ Andrew H. Lane by Jessica H. Paik, Attorney-in-Fact, Attorney-in-Fact
Stock symbol: ABT
Transactions as of: Nov 15, 2021
Transactions value $: -$1,300,090
Form type: 4
Date filed: 11/17/2021, 05:22 PM
Previous filing: Aug 31, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABT	Common shares without par value	Sale	-$1.3M	-10K	-11.62%	$130.01	76.1K	Nov 15, 2021	Direct	F1
holding	ABT	Common shares without par value						1.54K	Nov 15, 2021	Profit Sharing Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.03, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2	Balance in the Abbott Laboratories Stock Retirement Trust as of November 15, 2021.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.03, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Balance in the Abbott Laboratories Stock Retirement Trust as of November 15, 2021.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).